Amedeo's Top 20

Amedeo Smart

Independent Medical Education

06 March 2017

Multidisciplinary Journal Club

  1. Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, et al.
    Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Lancet 2017.

  1. Mok TS, Wu YL, Ahn MJ, Garassino MC, et al.
    Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
    N Engl J Med 2017;376:629-640.

  2. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, et al.
    Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
    N Engl J Med 2017;376:641-651.

  3. Carnicelli AP, De Caterina R, Halperin JL, Renda G, et al.
    Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.
    Circulation 2017.

  4. Cameron D, Piccart-Gebhart MJ, Gelber RD, Procter M, et al.
    11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
    Lancet 2017.

  1. Webster P, Lightstone L, McKay DB, Josephson MA, et al.
    Pregnancy in chronic kidney disease and kidney transplantation.
    Kidney Int 2017.

  2. Bai Y, Deng H, Shantsila A, Lip GY, et al.
    Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.
    Stroke 2017.

  3. Zetterlund LH, Frisell J, Zouzos A, Axelsson R, et al.
    Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
    Breast Cancer Res Treat 2017.

  4. Parkash R, Wells GA, Sapp JL, Healey JS, et al.
    The Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label, Clinical Trial (Substrate Modification with Aggressive Blood Pressure Control: SMAC- AF).
    Circulation 2017.

  5. Loomba R, Liang TJ.
    Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies and future directions.
    Gastroenterology 2017.

  1. Yang JC, Ahn MJ, Kim DW, Ramalingam SS, et al.
    Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.
    J Clin Oncol 2017.

  2. Caini S, Masala G, Saieva C, Kvaskoff M, et al.
    Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer 2017.

  3. Tosto G, Bird TD, Tsuang D, Bennett DA, et al.
    Polygenic risk scores in familial Alzheimer disease.
    Neurology 2017.

  4. Regolisti G, Antoniotti R, Fani F, Greco P, et al.
    Treatment of Metformin Intoxication Complicated by Lactic Acidosis and Acute Kidney Injury: The Role of Prolonged Intermittent Hemodialysis.
    Am J Kidney Dis 2017.

  5. Gastelum GM, Iqbal C, Hilsenbeck SG, Rimawi MF, et al.
    Retrospective review of genomic testing in breast cancer: Does it improve outcome?
    Breast Cancer Res Treat 2017.

  1. Mori T, Crandall CJ, Ganz DA.
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int 2017.

  2. Firuzyar T, Ghaedian T.
    The Effect of Antiseptic on 99mTc-DMSA Scans.
    Clin Nucl Med 2017;42:237-238.

  3. Roubille C, Rincheval N, Dougados M, Flipo RM, et al.
    Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohort.
    Ann Rheum Dis 2017.

  4. Li Y, Singer NG, Whitbred J, Bowen MA, et al.
    CD6 as a potential target for treating multiple sclerosis.
    Proc Natl Acad Sci U S A 2017.

  5. Larsen TB, Skjoth F, Nielsen PB, Kjaeldgaard JN, et al.
    Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ 2016;353:i3189.


more..

Privacy Policy